Change in Working Capital

$31.16M

TTM · Period ending: Jun 30, 2026 · USD

Latest reported$31.16Mperiod endingJun 30, 2026

CLDX Change in Working Capital ($12.30M → $31.16M)

Annual change in working capital

High-resolution chart · PNG

CLDX change in working capital history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Celldex Therapeutics Inc Change in Working Capital — Annual fiscal periods (USD)
Period ending	Change in Working Capital (USD)
Dec 31, 2025	14,058,000
Dec 31, 2024	-21,601,000
Dec 31, 2023	13,462,000
Dec 31, 2022	-3,898,000
Dec 31, 2021	-1,054,000
Dec 31, 2020	-299,000
Dec 31, 2019	-4,323,000
Dec 31, 2018	-15,372,000
Dec 31, 2017	-12,205,000
Dec 31, 2016	-6,560,000
Dec 31, 2015	10,887,000
Dec 31, 2014	6,128,000
Dec 31, 2013	7,678,000
Dec 31, 2012	4,420,000
Dec 31, 2011	2,367,000
Dec 31, 2010	-37,174,000
Dec 31, 2009	946,000
Dec 31, 2008	43,341,362
Dec 31, 2007	-1,347,514
Dec 31, 2006	43,666,732
Dec 31, 2005	9,951,430
Dec 31, 2004	1,138,800
Dec 31, 2003	-1,772,200
Dec 31, 2002	-4,452,300
Dec 31, 2001	-419,500
Dec 31, 2000	7,150,400
Dec 31, 1999	675,500
Dec 31, 1998	-2,800,000
Dec 31, 1997	-200,000
Dec 31, 1996	-800,000
Dec 31, 1995	-200,000
Dec 31, 1994	-900,000
Dec 31, 1993	1,800,000
Dec 31, 1992	-700,000
Apr 30, 1992	-300,000
Apr 30, 1990	-200,000
Apr 30, 1989	10,000,000
Apr 30, 1988	-10,000,000
Apr 30, 1987	12,300,000